Judge Trims SEC Fraud Case Over Cancer Drug Claims

By Carolyn Muyskens · March 25, 2026, 3:50 PM EDT

A Massachusetts federal judge greenlighted U.S. Securities and Exchange Commission claims against two of three former pharmaceutical executives accused of concealing from investors the U.S. Food and Drug Administration's "harsh critiques"...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Securities and Exchange Commission v. Carchedi et al

Case Number

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

March 12, 2025

Recent Articles By Carolyn

March 04, 2026
Judge Sets 'Hard Deadline' To Rule On Childhood Vax Policy
March 03, 2026
1st Circ. Won't Revive Boston's Opioid Claims Against PBMs
February 27, 2026
Judge Says RFK Jr.-Tied Group Can't Join Childhood Vax Suit
February 13, 2026
Docs Urge Judge To Block CDC's Childhood Vaccine Changes
February 11, 2026
Mass. AG Charges Medical Transport Co. With Billing Fraud
February 02, 2026
1st Circ. Judge Wary Of Boston Bid To Revive PBM Opioid Suit
January 30, 2026
Planned Parenthood Drops Medicaid Fight After 1st Circ. Loss
January 08, 2026
Trump Admin Can't Undo Block On Drug Rebate Program
January 07, 2026
Covenant Health Sued Over Patient Data Security Breach
January 06, 2026
RFK Jr. Can't Avoid Medical Groups' Challenge To Vax Policy